Skip to main content

Table 2 The clinical characteristics at baseline of the enrolled patients

From: Small dense low-density lipoprotein cholesterol was associated with future cardiovascular events in chronic kidney disease patients

Variable

All

CVs

Non- CVs

P a

(n = 145)

(n = 54)

(n = 91)

Men

113 (77.9 %)

45 (83.3 %)

68 (74.7 %)

0.227

Age(years)

65.2 ± 11.3

68.5 ± 10.5

63.2 ± 11.5

0.006

Body mass index(kg/m2)

23.9 ± 3.2

24.5 ± 3.3

23.6 ± 3.2

0.108

History of cardiovascular disease

 Previous myocardial infarction

26 (17.9 %)

10 (18.5 %)

16 (17.6 %)

0.887

 Stroke

3 (2.1 %)

1 (1.9 %)

2 (2.2 %)

0.998

 Peripheral vascular disease

5 (3.4 %)

2 (3.7 %)

3 (3.3 %)

0.998

Cardiovascular disease risk factors

 Hypertension

116 (80.0 %)

48 (88.9 %)

68 (74.7 %)

0.039

 Diabetes mellitus

65 (44.8 %)

32 (59.3 %)

33 (36.3 %)

0.007

 Dyslipidemia

123 (84.8 %)

46 (85.2 %)

77 (84.6 %)

0.926

 Smoking, current or former

63 (43.4 %)

23 (42.6 %)

40 (44.0 %)

0.873

 Family history

26 (17.9 %)

12 (22.2 %)

14 (15.4 %)

0.299

Etiology of CKD

 Diabetes

40 (27.6 %)

14 (25.9 %)

26 (28.6 %)

 

 Glomerulonephritis

22 (15.2 %)

7 (13.0 %)

15 (16.5 %)

 

 Hypertension

36 (24.8 %)

16 (29.6 %)

20 (22.0 %)

0.875

 Polycystic kidney disease

5 (3.4 %)

2 (3.7 %)

3 (3.3 %)

 

 Unknown

42 (29.0 %)

15 (27.8 %)

27 (29.7 %)

 

Medication

 Angiotensin receptor blocker

65 (44.8 %)

24 (44.4 %)

41 (45.1 %)

0.943

 Angiotensin converting enzyme inhibitors

27 (18.6 %)

14 (25.9 %)

13 (14.4 %)

0.082

 Insulin

7 (4.8 %)

3 (5.6 %)

4 (4.4 %)

0.753

 Antiplatelet

71 (48.9 %)

25 (46.3 %)

46 (50.6 %)

0.620

  1. Data are presented as mean ± SD or the number and its percentage (%). Percentage = the number of each individual category divided by n
  2. Abbreviation: CVs cardiovascular events
  3. aindicates the comparison of mean or percentage between Event group and Non-event group